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Abstract
In the course of our examination of proteins associated with the GLUT4-containing vesicles of rat adipocytes we have
identified a new 22 kDa member of the family of endoplasmic reticulum (ER) proteins known as reticulons. The protein,
which we refer to as vp20, was purified from a preparation of GLUT4-containing vesicles of rat adipocytes, and tryptic
peptides were micro-sequenced. From this information a cDNA encoding a single open reading frame for a protein of 22 kDa
was cloned. This protein is homologous to known members of the reticulon protein family. vp20 has two hydrophobic
stretches of about 35 amino acids that could be membrane spanning domains and an ER retention motif at its carboxy-
terminus. vp20 was most abundant in the high density microsome fraction of adipocytes, which is the fraction most enriched
in ER. Only a small fraction of vp20 was present in the GLUT4 vesicle population, and that fraction appears to be due to ER
vesicles that were non-specifically bound to the adsorbent. Analysis of tissue distribution of vp20 in rats revealed that it is
concentrated in muscle, fat and the brain. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Insulin stimulates the transport of glucose in fat
and muscle cells by causing the translocation of
the glucose transporter GLUT4 from an intra-
cellular location to the plasma membrane (PM)
[1]. The basis for this e¡ect is largely an enhance-
ment of the rate constant for externalization of
GLUT4 by insulin [2,3]. Intracellular GLUT4 is
most probably located in both endosomes and spe-
cialized insulin-regulatable secretory vesicles [4,5].
The enhanced rate constant for externalization is
likely to re£ect in part or entirely the enhanced
fusion of these insulin-regulatable vesicles with the
PM [6,7].
In order to search for other proteins that undergo
translocation in response to insulin, we and others
have undertaken the characterization of proteins in
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intracellular vesicles containing GLUT4 [8^11]. This
approach has led to the discovery of a novel mem-
brane aminopeptidase, now referred to as the insulin-
regulated aminopeptidase (IRAP) [12,13]. IRAP is
entirely colocalized with GLUT4 in adipocytes and,
like GLUT4, undergoes marked translocation to the
PM in response to insulin [5,14,15].
A number of other proteins have been found asso-
ciated with the GLUT4-containing vesicles. These
include the transferrin receptor [16], mannose
6-phosphate receptor [16], members of the cellubre-
vin family [17,18], secretory carrier-associated mem-
brane proteins [19], and sortilin [9,11]. These proteins
do not undergo such a marked translocation to the
PM as GLUT4 or IRAP in response to insulin, but
nonetheless do translocate to a smaller degree. In
addition, we have found a membrane-bound amine
oxidase in GLUT4-containing vesicles that does not
undergo translocation [10].
In the present study, we describe a 22 kDa pro-
tein (designated vp20) that was present in our prep-
aration of GLUT4 vesicles. This protein proved to
be a novel member of the family of proteins located
in the endoplasmic reticulum (ER) known as re-
ticulons. Moreover, it has an unusual tissue distribu-
tion.
2. Materials and methods
2.1. Antibodies
A rabbit antiserum was generated against the ami-
no-terminal peptide of rat vp20 (amino terminal 14
amino acids with Gly-Cys at the carboxy-terminal of
the peptide) conjugated via the Cys to keyhole limpet
hemocyanin. The anti-peptide antibodies were a⁄n-
ity-puri¢ed on the peptide conjugated to SulfoLink
(Pierce), as described in [20]. The antibodies against
GLUT4 were the a⁄nity-puri¢ed rabbit antibodies
against the carboxy-terminal 19 amino acids of
GLUT4 as described previously [13].
2.2. Adipocyte preparation
Rat adipocytes were obtained by collagenase di-
gestion of epididymal fat pads, as described by Web-
er et al. [21].
2.3. Puri¢cation and peptide analysis of vp20
The procedures used here have been previously
described in detail [10]. GLUT4 vesicles were isolated
from the low density microsome (LDM)/cytosol frac-
tion of adipocytes by immunoadsorption with anti-
bodies against the carboxy-terminus of GLUT4
bound to formaldehyde-¢xed Staphylococcus aureus
(Staph A) cells. The vesicle proteins were separated
by SDS gel electrophoresis, and the gel was stained
with Coomassie reagent (50% methanol, 10% acetic
acid, 40% water, 0.1% Coomassie blue R250) for 1 h
and then destained overnight with methanol/acetic
acid/water (10%/10%/80%). The stained 20 kDa pro-
tein band was excised from the gel following three
20 min washes with water.
The gel piece containing the 20 kDa protein was
subjected to in gel tryptic digestion as described by
Hellman et al. [22] but without the addition of 0.02%
Tween 20. The resulting peptide mixture was sepa-
rated by microbore high performance liquid chroma-
tography using a Zorbak C18 1.0 mm by 150 mm
reverse-phase column on a Hewlett-Packard 1090
HPLC/1040 diode array detector. Optimum fractions
were chosen based on di¡erential UV absorbance at
205 nm, 277 nm and 292 nm, peak symmetry, and
resolution, then further screened for length and ho-
mogeneity by matrix-assisted laser desorption time-
of-£ight mass spectrometry (MALDI-MS). Strategies
for peak selection, reverse-phase separation and Ed-
man microsequencing have been previously described
[23]. Tryptic peptides were subjected to automated
Edman degradation on an Applied Biosystems
477A or Procise 494-cLC protein sequencer (Foster
City, CA). To con¢rm sequence information, 5% of
the digest mixture was applied to microcapillary LC/
MS/MS on Finnigan LCQ quadrupole ion trap mass
spectrometer (San Jose, CA).
2.4. Cloning of rat vp20 cDNA
BLAST searches [24] revealed that three peptides
(aa 12^19, 82^97 and 165^178, see Fig. 1) out of the
four sequenced were homologous to sequences in the
human neuroendocrine speci¢c proteins (A46583,
I60903 and I60904) and the rat protein rS-Rex-s
(U17603). Also, in BLAST searches against the ex-
pressed sequence tag (EST) database the peptides
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produced matches against mouse (AA013623,
AA241811, AA542375, W85038, W33335,
AA433642, W62720, and AA057973) and human
(AA081840, W48742, AA303835, W48742, T71810,
W19258, AA131123, H96142, AA088462, N23613,
R96423, W47036, AA169734, AA196936,
AA192599, AA328277, T81226, T80234, AA193133,
AA111869, C15922, AA196311, AA329773,
AA100508, W68781, W68781, AA192565,
AA341035, W27023, AA341035, N77358) sequences.
Using the information derived from the compiled
mouse and human EST sequences two sense primers
were designed based on the peptides 82^97 (primer a,
321^343, GCCATATCAGAGGAAYTGGTTCA
where Y = C or T) and 98^111 (primer b, 348^370,
TATAGTAATTCTGCTYTNGGTCA where N = A,
T, C or G), and one antisense primer based on pep-
tide 165^178 (primer c, 549^571) (see Fig. 1 for nu-
cleotide and aa numbers).
Marathon-ready rat adipocyte cDNA (Clontech)
was initially ampli¢ed by PCR with primers a and
c and AmpliTaq Gold (Perkin-Elmer) (10 min at
94‡C, then 30 cycles of 1 min at 94‡C, 1 min at
51‡C, 1 min at 72‡C, followed by 7 min extension
at 72‡C). The product was puri¢ed with QIAquick
PCR puri¢cation kit (Qiagen) and ampli¢ed with
primers b and c under the same conditions as de-
scribed above. This gave the expected 224 bp frag-
ment, which was isolated from the gel piece with
QIAquick gel extraction kit (Qiagen), and cloned
into pCR-Script (Stratagene). The plasmids were pu-
ri¢ed (Wizard mini-preps, Promega) and sequenced
with primers b and c. From this sequence of 178 bp
(371^548), together with information from the ESTs
and primers a, b and c, two antisense primers, d and
e, for 5P rapid ampli¢cation of cDNA ends (RACE)
of the Marathon-ready rat adipocyte cDNA were
designed (primer d, 543^565; and primer e, 366^
392). 5P RACE was performed according to the man-
ufacturer’s (Clontech) instructions. The 5P RACE
product gave the sequence from 348 to 392.
With the sequence derived from the 5P RACE
product two sense primers (primer f, 348 to 328;
and primer g, 324 to 0) were designed and 3P RACE
of Marathon-ready rat adipocyte cDNA was per-
formed according to the manufacturer’s instructions.
The 3P RACE product was sequenced with primer a.
Based on the 3P RACE product sequence two addi-
tional antisense primers were designed (primer h,
852^876, and primer i, 741^762). The 3P RACE
product was further ampli¢ed with primers g and
h, and Advantage cDNA Polymerase Mix (Clontech)
(1 min at 94‡C, 30 cycles of 1 min at 94‡C, 1 min at
56‡C, 3 min at 72‡C, and a ¢nal extension for 10 min
at 72‡C). This product was then puri¢ed with QIA-
quick PCR puri¢cation kit and ampli¢ed with prim-
ers g and i under the same conditions. This product
(324 to 762) was sequenced at least three times in
each direction using primers a, d, e, g, i and j (sense
primer j, 519^548).
Sequencing was performed on the Applied Biosys-
tems 373 DNA Sequencing System with the Perkin-
Elmer DNA Sequencing Kit FS.
2.5. Subcellular fractionation
Rat adipocytes were either left in the basal state or
treated with 10 nM insulin for 30 min. The cells were
then fractionated into PM, LDM, high density mi-
crosomes (HDM), mitochondria/nuclei, and cytosol
by di¡erential centrifugation, as described in [25].
2.6. Rat tissue preparation
The method used for the preparation of rat tissues
was similar to that outlined in [13]. Rat tissues were
homogenized in 4^6 volumes of 25 mM HEPES,
100 mM NaCl, 1 mM sodium vanadate, 20 mM
sodium pyrophosphate, 3 mM N-ethylmaleimide,
1 Wg/ml pepstatin, 10 WM EP475, 10 Wg/ml aprotinin,
10 WM leupeptin, and 1 mM phenylmethylsulfonyl
£uoride, pH 7.4. The homogenates were assayed
for protein concentration and diluted to 6.7 mg/ml
with homogenization bu¡er. One-third volume of
concentrated SDS sample bu¡er (16% SDS, 400 mM
Tris-HCl, 40 mM dithiothreitol, 4 mM EDTA, 40%
glycerol, 4 mM sodium vanadate, 4 Wg/ml pepstatin,
40 WM EP475, 40 Wg/ml aprotinin, 40 WM leupeptin,
and 4 mM phenylmethylsulfonyl £uoride, pH 6.8)
was added, and the samples were held at 100‡C for
5 min, cooled, and microfuged brie£y to remove any
insoluble material.
2.7. Immunoblotting
Immunoblotting of GLUT4 was performed as de-
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scribed in [14]. The same procedure was used for
blotting vp20 (antibody concentration, 10 Wg/ml).
The relative intensities of the bands on each blot
were quantitated by computer enhanced video densi-
tometry using the program NIH Image (developed at
the US National Institutes of Health and available
on the Internet at http://rsb.info.nih.gov/nih-image/),
and the relative amounts of each protein were calcu-
lated from the standard curve given by a dilution
series of the protein run on each blot (see Figs. 2
and 3).
3. Results
3.1. Identi¢cation, cloning and structural analysis of
vp20
GLUT4 vesicles were isolated from the LDM of
rat adipocytes by immunoadsorption with antibodies
against GLUT4, as described in Section 2. A control
immunoadsorption was done with irrelevant antibod-
ies. The vesicles contained a 20 kDa polypeptide,
detected by protein staining after electrophoresis,
that appeared less abundant in the control immu-
noadsorbate (data not shown; see Fig. 4 of [26] for
similar data for GLUT4 vesicles from 3T3-L1 adipo-
cytes). Isolation of GLUT4 vesicles from approxi-
mately 10 mg of LDM (adipocytes from 96 rats)
yielded su⁄cient amounts of vp20 to allow the mi-
crosequencing of tryptic peptides (see Fig. 1).
An examination of the EST database using
BLAST [24] showed that the four peptides or closely
related ones were encoded by a number of mouse
and human ESTs, and that the human ESTs could
be assembled to give an open reading frame for the
full protein (Fig. 1).
With the information derived from the peptides
and EST sequences a series of PCR primers were
designed, and these were employed to amplify a spe-
ci¢c region of the cDNA encoding rat vp20. From
this sequence further primers were designed, as out-
lined in Section 2, and 5P RACE was performed. The
sequence information obtained from 5P RACE was
used to carry out 3P RACE. Finally, the sequence of
the 3P end of the 3P RACE product was used to
design antisense primers, and these allowed PCR am-
pli¢cation of the complete open reading frame of rat
vp20.
The cDNA for rat vp20, which has been reported
to GenBank (AF051335), is given in Fig. 1. This
sequence contains an open reading frame from nt
57 to nt 656 which encodes a 22 406 Da protein of
199 amino acids. The methionine at nt 57^59 is al-
most certainly the site of initiation because there is
an in-frame upstream stop codon at nt 24^26 and the
sequence surrounding the methionine conforms well
to the consensus sequence for the initiation of trans-
lation in rat [27].
Analysis of the amino acid sequence revealed two
long hydrophobic stretches of 37 and 35 amino acids
(boxed in Fig. 1). These stretches may be transmem-
brane segments although they are much longer than
the typical transmembrane segments of approxi-
mately 20 amino acids. There were no other func-
tional domains as determined by comparative se-
quence analysis [28]. Analysis using PSORTII [29]
indicates that the protein does not contain an N-ter-
minal signal sequence. Data from subcellular fractio-
nation described below indicate that vp20 is located
in the ER. This location is further suggested by the
presence of the ER retention motif KRKAD at the
carboxy-terminus [30].
The amino acid sequence of rat vp20 is 66% iden-
Fig. 1. cDNA and amino acid sequence of rat vp20. The nucleotide sequence of the cDNA encoding rat vp20 together with the pre-
dicted amino acid sequence (accession number AF051335 corresponding to bp 1^764) are given. The putative hydrophobic sequences
in vp20 are boxed (aa 25^61 and 128^162) and the sequenced tryptic peptides are underlined (12^19, 82^97, 98^111 and 165^178). Be-
low the amino acid sequence of rat vp20 are the sequence of human vp20 constructed from the EST database (AA081840, W48742,
AA303835, W48742, T71810, W19258, AA131123, H96142, AA088462, N23613, R96423, W47036, AA169734, AA196936, AA192599,
AA328277, T81226, T80234, AA193133, AA111869, C15922, AA196311, AA329773, AA100508, W68781, W68781, AA192565,
AA341035, W27023, AA341035, N77358) and that of the rat protein rS-Rex-s (U17603). Asterisks represent identical amino acids.
The DNA was sequenced at least three times in each direction, except for region 348 to 0 which was only sequenced in the antisense
direction, and region 765^905, which was only sequenced in the sense direction. These two regions (shown in lower case) are included
here to aid in the description of the cloning and were not submitted to GenBank.
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tical to a previously cloned rat protein known as
rS-Rex-s [31] (Fig. 1). This latter protein is a member
of a large family of proteins of unknown function,
now called the reticulon family because members
have been localized to the ER (see Section 4).
Thus, vp20 is a novel member of the reticulon family.
3.2. Subcellular distribution of vp20 in rat adipocytes
The presence of vp20 in our preparation of
GLUT4 vesicles led us to compare the subcellular
distribution of vp20 with that of GLUT4. In order
to detect vp20, an antibody against the amino-termi-
nal 14 amino acids was generated. Since rS-Rex-s
di¡ers by nine out of 14 amino acids in this regions
(Fig. 1), this antibody should not detect rS-Rex-s.
Subcellular fractions from unstimulated and insulin-
treated rat adipocytes were analyzed for vp20 and
GLUT4 by immunoblotting (Fig. 2). In unstimulated
cells vp20 was most abundant in the high density
microsomes (HDM) but also present in the LDM
and PM. Assays of the various adipocyte subcellular
fractions for organelle markers have shown that the
ER is highly enriched in the HDM fraction, but is
also present in the LDM and, to a lesser extent, in
the PM fraction [21,25]. As expected from previous
studies [25], GLUT4 was mainly in the LDM. Upon
insulin treatment the amount of GLUT4 in the PM
increased by 5.1 þ 1.2 (S.E.M.) fold and decreased in
the LDM of 0.6 þ 0.1 fold. These changes are similar
to those previously reported by us [9]. On the other
hand, vp20 showed no change in distribution in the
LDM or PM samples but a small increase (2.0 þ
0.5 fold) in the HDM was observed.
In order to determine the extent of colocalization
of vp20 with GLUT4 in the LDM fraction, we meas-
ured the proportion of vp20 in the LDM that was in
GLUT4 vesicles. Vesicles were isolated from the
LDM by immunoadsorption; and then the original
LDM, the depleted LDM, and the GLUT4 vesicles
were analyzed for vp20, as well as for GLUT4, by
immunoblotting (Fig. 3). Approximately 80% of the
Fig. 3. vp20 in GLUT4 vesicles from rat adipocytes. GLUT4
vesicles were adsorbed from the LDM of unstimulated rat adi-
pocytes with anti-GLUT4 (G) or irrelevant rabbit IgG antibod-
ies (C) on Staph A cells as described in [9]. The vesicle proteins
were solubilized with nonylethyleneglycol dodecyl ether (C12E9),
and any proteins remaining bound to the antibody-Staph A ad-
sorbent, which included the GLUT4, were solubilized with SDS
sample bu¡er. The relative amounts of vp20 and GLUT4 in the
LDM, depleted LDM after adsorption (DEP), the C12E9-solubi-
lized GLUT4 vesicles (VES), and the SDS eluate of the Staph
A cells (SDS) were determined by immunoblotting. The samples
labeled load 1 were derived from 3 Wg of LDM. The other
lanes contained the designated fraction or multiple of this load.
The band above 50 kDa in the SDS G and C lanes for
GLUT4 are due to the heavy chain of the adsorbing antibodies.
Immunoreactive bands are labeled on the left of the ¢gure and
the positions of molecular weight markers (kDa) are shown on
the right. A repetition of this entire experiment yielded similar
results.
Fig. 2. Subcellular distribution of vp20 and GLUT4 in rat adi-
pocytes. LDM, PM, HDM, mitochondria/nuclei (M/N), and cy-
tosol (CYT), from untreated (3) or insulin-treated (+) rat adi-
pocytes were isolated, and separated by SDS gel
electrophoresis. The proteins were transferred to the nitrocellu-
lose membrane, which was cut at the 30 kDa marker, and the
upper and lower parts were immunoblotted for GLUT4 and
vp20, respectively. Except for lanes 1^4 the amount of protein
loaded per lane was 0.5 Wg. Lanes 1^4 contained untreated
LDM at 4, 2, 1/4, and 1/2 the 0.5 Wg load. Immunoreactive
bands are labeled on the left of the ¢gure, and the positions of
molecular weight markers (kDa) are shown on the right. A rep-
etition of this entire experiment yielded similar results.
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GLUT4 in the LDM was speci¢cally adsorbed, as
measured by the percent depletion (Fig. 3, lane 6
vs. 5). This is also evidenced by the recovery of
GLUT4 upon SDS treatment of the adsorbent
(lane 10). On the other hand only a small amount,
8%, of the vp20 in the LDM, was found in GLUT4
vesicles (Fig. 3, lane 8 vs. 5). Surprisingly, approxi-
mately the same amount of vp20 was present in the
material adsorbed from the LDM with irrelevant
antibodies (lane 9). This ¢nding indicates that vp20
was not a component of the GLUT4 vesicles, but
rather was present in the membranes that were
bound nonspeci¢cally by the absorbent. The discrep-
ancy between this result and the observation that
GLUT4 vesicles appear to contain a speci¢c 20 kDa
protein, as detected by protein staining (described
above), remains to be resolved.
3.3. Tissue distribution of vp20 and GLUT4
Samples of various tissues were prepared from rats
and examined by immunoblotting for the presence of
vp20 and GLUT4 (Fig. 4). As expected from pre-
vious studies [1], GLUT4 was present in the muscle
and adipose tissues. The distribution of vp20 was
strikingly similar to that of GLUT4, with the excep-
tion of the brain, where vp20 was detected and
GLUT4 was not.
4. Discussion
In this study we have cloned and identi¢ed a new
22 kDa member of the reticulon protein family. This
family was originally discovered as a group of three
alternative mRNA transcripts from a single gene ex-
pressed in human endocrine cells [32,33]. These three
transcripts encode proteins of 776, 356, and 208 ami-
no acids that are identical over their carboxy-termi-
nal 188 amino acids. These proteins were designated
NSP-A, NSP-B, and NSP-C, respectively, where
NSP refers to neuroendocrine speci¢c protein. Sub-
sequently the rat homolog of NSP-C, named rS-Rex-
s, was cloned [31]. vp20 is similar to, but not identi-
cal with rS-Rex-s, and is thus encoded by a di¡erent
rat gene. Correspondingly, the human equivalent of
vp20, deduced from the EST database, is similar to,
but not identical with NSP-C, and thus is the prod-
uct of a di¡erent gene.
A recent report from Roebroek et al. describes a
new NSP-like human gene that directs expression of
three mRNA transcripts encoding three proteins with
an identical carboxy-terminal segment of 201 amino
acids that is homologous with the conserved 188
amino acids in the carboxy-terminus of the NSPs
[34]. Human vp20 is only 50% identical to the corre-
sponding 205 aa protein in this group, and thus it is
also not the product of the NSP-like gene.
Because the transcripts from this new human
NSP-like gene are not limited in expression to neuro-
endocrine cells, Roebroek et al. renamed the proteins
reticulons, for their location in the ER (see below).
The NSP gene is now known as RTN1 (RTN for
reticulon) and the NSP-like gene has been designated
RTN2 [34]. These authors also report that searches
of the EST database, and unpublished Northern
blots, indicate the existence of two additional human
genes encoding proteins homologous to the carboxy-
terminal 200 amino acid region of the RTN1 and
RTN2 proteins [33^35]. These genes have been des-
ignated RTN3 and RTN4. The cDNA encoding hu-
man vp20 is identical to one of the transcripts from
RTN4, since several of the ESTs that we used to
construct the human vp20 protein (T71810,
T81266) are the same as ones reported by Roebroek
et al. as arising from RTN4.
The rS-Rex/NSP/RTN1 proteins, the RTN2 pro-
teins, and as shown here, the vp20/RTN4 protein
Fig. 4. Tissue distribution of vp20 and GLUT4. SDS samples
of rat tissues were separated by gel electrophoresis and immu-
noblotted for GLUT4 and vp20. Each lane contained 200 Wg of
protein from the designated tissues, except for the LDM lane,
which contained 1 Wg of LDM from rat adipocytes. Abbrevia-
tions: Gastro, gastrocnemius; Quads, quadriceps; BAT, brown
adipose tissue; WAT, white adipose tissue. Immunoreactive
bands are labeled on the left of the ¢gure and the positions of
molecular weight markers (kDa) are shown on the right. A rep-
etition of this entire experiment yielded similar results.
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each contain a carboxy-terminal region with two
long hydrophobic stretches, which may be transmem-
brane segments [36]. In addition, the RTN2 and
vp20/RTN4 proteins terminate in the ER retention
motif KXKXX, and the rS-Rex/NSP/RTN1 protein
has a related carboxy-terminal sequence, KRHAE.
The rS-Rex/NSP/RTN1 proteins have been shown
to be integral membrane proteins of the ER [35,37].
Our results from subcellular fractionation indicate
that the vp20/RTN4 protein is also located in the
ER. The RTN2 and RTN3 proteins are likely to
have the same cellular location.
The various RTN proteins exhibit characteristic
tissue distributions. mRNA transcripts for the
rS-Rex/NSP/RTN1 proteins are expressed mainly in
the brain [31,32,34]. Those for RTN2 proteins are
found in most tissues, with the greatest abundance
in skeletal muscle [34]. Our data show that vp20/
RTN4 protein is expressed primarily in muscle, fat,
and brain. Data for RTN3 transcripts have not yet
been reported [34].
A major unresolved question is the function of the
RTN proteins. Recent studies have shown that spe-
ci¢c ER membrane proteins are required for the
transport of speci¢c proteins from the ER to the
Golgi [38^40]. Each of these ER membrane proteins
may function to direct proper assembly of speci¢c
proteins in the ER and/or chaperone their vesicular
transport to the Golgi. An attractive hypothesis is
that the RTN proteins function in this manner.
The fact that there is a family of them with unique
tissue distribution would allow various RTN proteins
to interact with various target proteins that are pro-
ceeding through the ER/Golgi biosynthetic pathways
in various tissues.
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